Hinge Health is headquartered in San Francisco, California, USA. The company primarily operates in the United States, where it serves large employers, health plans, and public sector organizations.
Hinge Health, founded in 2014, has emerged as a leader in digital musculoskeletal (MSK) care, offering innovative solutions to address chronic back and joint pain. Their comprehensive platform integrates advanced technology with personalized clinical care, setting a new standard in the treatment and prevention of MSK disorders.
Innovative Products
At the core of Hinge Health’s offerings is their digital clinic, which combines wearable sensors, computer vision technology, and artificial intelligence to deliver real-time, full-body motion tracking during exercise therapy. This technology provides users with immediate feedback, enhancing engagement and improving outcomes. Additionally, the platform offers guided breathing exercises and other personalized interventions, empowering individuals to manage pain effectively and prevent future issues.
Target Clients & Expansion
Hinge Health primarily serves large employers and health plans, aiming to reduce healthcare costs associated with MSK conditions. Their client portfolio includes Fortune 500 companies such as Boeing, Salesforce, and US Foods, as well as over 300 health plans and public sector organizations. By partnering with these entities, Hinge Health provides employees and members with accessible, high-quality MSK care, leading to decreased pain, reduced surgeries, and lower opioid use.
Its key markets are as follows:
- United States: This remains Hinge Health’s primary market, where it provides digital MSK care solutions to major corporations like Boeing and Salesforce.
- United Kingdom: The company has expanded into the UK, offering its services to European employers and health systems.
- Canada & Australia: These markets have growing demand for digital health solutions, and Hinge Health has shown interest in international expansion, though details remain limited.
- Potential Future Markets: Given its growth strategy, Hinge Health may expand further into Europe and Asia, where digital health adoption is increasing.
Funding and Financial Overview
Hinge Health has secured substantial investment to fuel its growth and innovation. In October 2021, the company raised $400 million in a Series E financing round led by Tiger Global Management and Coatue Management, reaching a valuation of $6.2 billion. This followed a $300 million Series D round in January 2021, jointly led by Coatue Management and Tiger Global, which valued the company at $3 billion. Over $1 billion has been invested in Hinge Health, enabling the expansion of one of the largest clinical, data science, and R&D teams in digital health.
Regarding financial performance, Hinge Health reported a 33.4% increase in revenue to $390.4 million for 2024, with net losses significantly reduced from $108.1 million in 2023 to $11.9 million in 2024. The company has filed for an initial public offering (IPO) in New York, signalling strong growth and confidence in its future prospects.
Nordic Investors – While Hinge Health has attracted a diverse group of investors, specific information about participation from Nordic investors is not readily available. Notably, European venture capital firm Atomico, founded by Swedish entrepreneur Niklas Zennström, participated in the company’s Series A, B, C, and D funding rounds, indicating a high level of Nordic investment in Hinge Health’s growth.
Photo: Hinge Health
